Physostigmine reverses MK-801-induced but not amphetamine-induced effects on latent inhibition: focus on cholinergic treatments in schizophrenia

被引:3
作者
Barak, S. [1 ]
Weiner, I. [1 ]
机构
[1] Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1016/S0924-977X(06)70568-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S440 / S441
页数:2
相关论文
共 3 条
[1]
Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice [J].
Csernansky, JG ;
Martin, M ;
Shah, R ;
Bertchume, A ;
Colvin, J ;
Dong, HX .
NEUROPSYCHOPHARMACOLOGY, 2005, 30 (12) :2135-2143
[2]
Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists [J].
Friedman, JI .
PSYCHOPHARMACOLOGY, 2004, 174 (01) :45-53
[3]
Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol [J].
Gaisler-Salomon, I ;
Weiner, I .
PSYCHOPHARMACOLOGY, 2003, 166 (04) :333-342